We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy and are not allowing patients to have people with them during appointments. This is just one more way of ensuring your safety and that of our staff. Read more
Transcriptional & Epigenetic Control of Helper T Cell Differentiation
Tea will be served at 1:15 pm.
This program is for the research community.
Date & Time(s)
Hospital for Special Surgery
535 East 70th Street
Second Floor Conference Center
New York, New York
John O’Shea, MD
Scientific Director & Chief
Molecular Immunology and Inflammation Branch